Volta Labs — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Volta Labs is a private, revenue-generating company providing a platform technology for automated NGS sample preparation. Its core innovation is the Callisto™ system, which uses digital microfluidics (electrowetting) to miniaturize and automate complex library prep and hybridization capture workflows with high robustness and reduced costs. The company targets the high-growth genomics market by offering a sequencer- and sample-agnostic solution designed to improve laboratory efficiency and data quality for applications like whole genome and targeted sequencing.

Genetics & Genomics

Technology Platform

Digital microfluidics (electrowetting) platform for automated, miniaturized NGS sample preparation (Callisto™ System).

Opportunities

The growing demand for automated, cost-effective, and consistent sample prep in the expanding NGS market, particularly for complex applications like long-read sequencing and low-input samples.

Their sequencer-agnostic platform allows them to capitalize on growth across all major sequencing technologies.

Risk Factors

Facing intense competition from established life science automation giants and NGS vendors.

Risks include technology adoption hurdles, scaling manufacturing, and executing on its product roadmap in a timely manner to stay ahead of competitors.

Competitive Landscape

Competes with large automation companies (Agilent, Tecan, PerkinElmer) and NGS-focused automation solutions from Illumina and others. Differentiation lies in its proprietary digital microfluidics technology, which enables unique benefits in miniaturization and gentle handling for long DNA fragments.

More companies in Diagnostics & Precision Medicine →More companies in United States →